The role of AMH in anovulation associated with PCOS: a hypothesis
- PMID: 24770999
- DOI: 10.1093/humrep/deu076
The role of AMH in anovulation associated with PCOS: a hypothesis
Abstract
Polycystic ovary syndrome (PCOS) is the most common cause of infertility due to anovulation. Despite its prevalence, the precise cause of the anovulation is yet to be clearly defined. There is an increased number of pre-antral and antral follicles in the polycystic ovary, many of which individually produce increased amounts of anti-Müllerian hormone (AMH) compared with those in the normal ovary. In this article, it is hypothesized that the high AMH concentrations present in women with PCOS play an integral role in causing anovulation due to its inhibitory influence on the actions of follicle-stimulating hormone, which normally promotes follicular development from the small antral to the ovulatory stage.
Keywords: anovulation; anti-Müllerian hormone; pathophysiology; polycystic ovarian syndrome.
Similar articles
-
The role of anti-Müllerian hormone in the pathogenesis and pathophysiological characteristics of polycystic ovary syndrome.Eur J Obstet Gynecol Reprod Biol. 2016 Apr;199:82-7. doi: 10.1016/j.ejogrb.2016.01.029. Epub 2016 Feb 10. Eur J Obstet Gynecol Reprod Biol. 2016. PMID: 26914398 Review.
-
[Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].Akush Ginekol (Sofiia). 2013;52 Suppl 1:16-23. Akush Ginekol (Sofiia). 2013. PMID: 24294740 Bulgarian.
-
Changes in serum anti-mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome.J Clin Endocrinol Metab. 2007 Nov;92(11):4138-43. doi: 10.1210/jc.2007-0868. Epub 2007 Aug 14. J Clin Endocrinol Metab. 2007. PMID: 17698904
-
Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.Hum Reprod. 2013 Mar;28(3):762-9. doi: 10.1093/humrep/des460. Epub 2013 Jan 14. Hum Reprod. 2013. PMID: 23321213
-
Anti-müllerian hormone in the pathophysiology and diagnosis of polycystic ovarian syndrome.Curr Opin Endocrinol Diabetes Obes. 2018 Dec;25(6):377-384. doi: 10.1097/MED.0000000000000445. Curr Opin Endocrinol Diabetes Obes. 2018. PMID: 30299432 Review.
Cited by
-
Differences in metabonomic profiles of abdominal subcutaneous adipose tissue in women with polycystic ovary syndrome.Front Endocrinol (Lausanne). 2023 Feb 24;14:1077604. doi: 10.3389/fendo.2023.1077604. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36909330 Free PMC article.
-
lnc-MAP3K13-7:1 Inhibits Ovarian GC Proliferation in PCOS via DNMT1 Downregulation-Mediated CDKN1A Promoter Hypomethylation.Mol Ther. 2021 Mar 3;29(3):1279-1293. doi: 10.1016/j.ymthe.2020.11.018. Epub 2020 Nov 17. Mol Ther. 2021. PMID: 33212300 Free PMC article.
-
Animal Models for Human Polycystic Ovary Syndrome (PCOS) Focused on the Use of Indirect Hormonal Perturbations: A Review of the Literature.Int J Mol Sci. 2019 Jun 3;20(11):2720. doi: 10.3390/ijms20112720. Int J Mol Sci. 2019. PMID: 31163591 Free PMC article. Review.
-
Transcription factor YY1 adversely governs ovarian granulosa cell growth in PCOS by transcription activation-mediated CDKN1C upregulation.Funct Integr Genomics. 2024 Sep 25;24(5):171. doi: 10.1007/s10142-024-01448-2. Funct Integr Genomics. 2024. PMID: 39317806
-
Brown Adipose Transplantation Improves Polycystic Ovary Syndrome-Involved Metabolome Remodeling.Front Endocrinol (Lausanne). 2021 Nov 29;12:747944. doi: 10.3389/fendo.2021.747944. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34912296 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
